Traditional Chinese medicine composition for treating achalasia of cardia

Abstract

The invention discloses a traditional Chinese medicine composition for treating achalasia of cardia. A recipe of the traditional Chinese medicine composition is prepared from the following components: 10-30g of radix rehmanniae preparata, 10-15g of radix morindae officinalis, 10-30g of fructus corni, 10-30g of herba dendrobii, 10-15g of herba cistanche, 6-12g of fructus schisandrae, 6-12g of ramulus cinnamomi, 10-30g of white poria cocos, 10-30g of radix ophiopogonis, 6-15g of stem and leaf of acorus calamus, 6-15g of radix polygalae, 10-30g of rhizoma pinelliae, 10-30g of root of adenophora stricta, 10-30g of radix salvia miltiorrhizae, 3-12g of bulbus fritillariae cirrhosae, 10-30g of fructus citri sarcodactylis, 10-30g of rhizoma polygonati odorati, 30-60g of radix astragali preparata, 15-30g of radix codonopsis, 10-15g of endothelium corneum gigeriae galli, 10-15g of radix clematidis, 10-15g of herba of ocimum basilicum, 10-15g of fruit of pawpaw, 0.3-0.6g of semen strychni, 15-30g of herba agrimoniae, 6-15g of inula flower and 10-30g of red ochre. The traditional Chinese medicine composition has the effects of reinforcing yin and yang, nourishing qi and blood, ascending spleen and descending stomach, strengthening body resistance and eliminating evil, and has the advantages of short treatment time, excellent effect and high curative rate.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine composition for treating achalasia, and belongs to the technical field of traditional Chinese medicine. Background technique [0002] Achalasia, also known as cardia spasm and megaesophagus, is a common digestive dysfunction disease in clinical practice, which is related to the damage or disease of esophageal muscle. The incidence of this disease is relatively high, and the age of onset is generally 13-77 years old, among which the most common age is 20-39 years old, accounting for 4%-7% of esophageal diseases, and there is no obvious relationship with gender. Clinically, the disease mainly manifests as dysphagia, vomiting and regurgitation. Patients with regurgitation at night are likely to stray into the trachea, resulting in pulmonary infection. In addition, patients often suffer from malnutrition, weight loss, and more severe symptom...

AI Technical Summary

Problems solved by technology

Clinically, the disease mainly manifests as dysphagia, vomiting and regurgitation. Patients with regurgitation at night are likely to stray into the trachea, resulting in pulmonary infection. In addition, patients often suffer from malnutrition, weight loss, and more severe symptoms due to long-term dysphagia. Some people can't take in food and water at all, and can only rely on fluid replacement to maintain nutrition

The clinical treatment of this disease mainly includes surgical treatment, drug treatment, and balloon expansion, etc., but surgical treatment is relatively traumatic, expensive, and has a high incidence of various complications; drug treatment has a short action time and causes many adverse reactions, such as Headache, hypotension, lower extremity edema, etc.